CHICAGO, Nov. 06, 2019 (GLOBE NEWSWIRE) — The global size is anticipated to grow from USD 20.0 in 2019 to USD 27.5 billion by 2024, based on the findings in MarketsandMarkets’s study, “Infection Control Market by Product (Disinfection [Disinfectant, Wipes, Sprays, Liquids, Disinfectors, UV, Wraps], AER, Sterilization [Steam, Hydrogen Peroxide, Radiation, Indicators, Services]), End User (Hospitals, Life Science)-Global Forecast to 2024”. Numerous factors drive the growth of the global infection control industry, including incidences of hospital-acquired infections (HAIs), an increasing number of surgical procedures, and the growing number of cases of chronic diseases across the world.

The study segments the global infection control market into cleaning & disinfection products, sterilization products & services, endoscope reprocessing products, protective barriers, and other infection control products. The report provides a further deep-dive of these segments into various sub-segments. For instance, cleaning & disinfection products are segmented further into disinfectants, lubricants and cleaning solutions, cleaning and disinfection equipment, and disinfection and cleaning accessories.

Download PDF Brochure:

An analysis of these products and services shows that the sterilization products & services held the largest global infection control market share in 2018. The increasing number of surgeries, the prevalence of HAIs, and growing initiatives & regulatory actions undertaken by numerous governments across the world to ensure essential infection control standards are driving the growth of the sterilization products and services market. However, the endoscope reprocessing products segment is expected to grow at the highest CAGR during the forecast period. The increasing importance of diagnostic and therapeutic endoscopy procedures, advanced technologies, reasonably stable reimbursement scenarios, and concerns regarding patient-to-patient cross-infection caused due to improper endoscope reprocessing is driving the growth of this segment.

Hospitals & clinics, medical device companies, pharmaceutical companies, life sciences industry, and food industry, among others, are some of the major end-users of the infection control and prevention market. Of these, Hospitals & clinics, and medical device companies together accounted for more than half the global infection control market share in 2018. The overall demand for infection control in hospitals is driven primarily by the increasing prevalence of HAIs and the rising geriatric population (as this population segment is more susceptible to various chronic diseases). The growing volume of surgical procedures performed is also a major contributor to the growth of the infection control industry for hospitals.

North America contributed to the largest revenue share of the global infection control product and services market in 2018. The growing demand for healthcare services, rising number of surgeries, and the need for infection control to combat HAIs are some of the key factors driving the growth of the market in North America. However, the Asia Pacific infection control market is expected to register the highest growth rate (CAGR) during the forecast period. The growing geriatric population, rising number of hospitals, expanding pharmaceutical and medical device industries, and increasing incidence of HAIs are driving the growth of the market in the Asia Pacific.

The growing healthcare sector (especially in emerging economies), increasing utilization of e-beam sterilization techniques, and the rising importance of single-use medical devices & nonwovens are expected to provide new opportunities for the growth of the infection control market in the near future. Additionally, to prevent costly and life-threatening HAIs, an increasing number of hospitals are deploying disinfection robots that destroy bacteria such as Clostridioides Difficile (CD). Compared to traditional room disinfection systems, UV disinfection robots are an efficient and environmentally friendly way to destroy pathogens in healthcare rooms and reduce the occurrence of HAIs.

Many hospitals and market players are collaborating with infection control market players offering UV disinfection robots to control the occurrence of HAIs. For example, in September 2015, Serenus Biotherapeutics (Kenya), a biopharmaceutical company, collaborated with Xenex (US) to provide the Xenex pulsed xenon Full-Spectrum ultraviolet (UV) room disinfection system at the Infection Prevention Network-Kenya, or IPNET-K Conference 2015 in the country to improve the quality of healthcare in African health settings. Besides, companies are also focusing on acquiring their competitors. For instance, STERIS acquired Harwell Dosimeters Limited (UK) in September 2017, for providing its global customers with a broad range of contract sterilization and laboratory testing services.

Request Sample Pages:

The major players in the global infection control market include Getinge (Sweden), Ecolab (US), Sotera Health (US), the MMM Group (Germany), STERIS (US), Reckitt Benckiser (UK), Pal International (UK), Matachana (Spain), Metrex Research (US), Advanced Sterilization Products (US), 3M (US), Belimed (Switzerland), Miele (Germany), Melag (Germany), and Cantel Medical (US). This is a highly diversified and competitive market that has many players operating at regional and local levels.

Browse Related Reports:

by Process (Presoak, Manual Cleaning, Automatic Cleaning, Disinfection) Type (Enzymatic & Non-enzymatic Detergent) Application (Surgical Instruments, Endoscope, Ultrasound Probe) – Global Forecast to 2022

by Product & Service (Instrument (Heat, Filtration, Low Temperature), Consumables and Accessories (Detergents, Indicators), Services (E beam, Gamma)), End User (Hospitals, Pharmaceutical Companies) – Global Forecast to 2023

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

:
Mr. Shelly Singh
MarketsandMarkets™ INC.

630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +

Visit Our Website: